RALEIGH, N.C., Feb. 15, 2011 /PRNewswire/ -- Pioneer Surgical Technology today announces the market launch of their new portfolio of biologic products, Legato, designed to be used in extremity, trauma, and general orthopaedic indications.
Legato Bone Void Filler will be showcased during the 2011 American Academy of Orthopaedic Surgeons (AAOS) convention in San Diego this week. Legato is a resorbable, collagen-based implant that acts as a scaffold for the in-growth of new bone and is designed to have broad appeal in extremity, trauma and general orthopaedic indications. In addition, Legato forms a cohesive and adhesive product easily shaped to defects while maximizing direct contact with host bone.
Regarding Pioneer's latest product introduction Mr. Shane Ray, General Manager – Biologics for Pioneer stated, "We are very pleased to expand our product offerings with Legato into the extremities, trauma and general orthopaedics market. Our goal has always been to establish highly effective products first in spine and now expanding into additional high growth markets such as extremities. We saw incredible sales growth in 2010 and are executing our 2011 growth plans to expand our product offerings within and outside the United States."
For more information regarding Pioneer's Biologics offerings including Legato, please visit the Pioneer Surgical website at www.pioneersurgical.com.
About Pioneer Surgical Technology, Inc.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopaedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopaedic, Spine, and Biologics divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products, visit www.pioneersurgical.com.
SOURCE Pioneer Surgical Technology, Inc.
Advertisement
Legato Bone Void Filler will be showcased during the 2011 American Academy of Orthopaedic Surgeons (AAOS) convention in San Diego this week. Legato is a resorbable, collagen-based implant that acts as a scaffold for the in-growth of new bone and is designed to have broad appeal in extremity, trauma and general orthopaedic indications. In addition, Legato forms a cohesive and adhesive product easily shaped to defects while maximizing direct contact with host bone.
Advertisement
Regarding Pioneer's latest product introduction Mr. Shane Ray, General Manager – Biologics for Pioneer stated, "We are very pleased to expand our product offerings with Legato into the extremities, trauma and general orthopaedics market. Our goal has always been to establish highly effective products first in spine and now expanding into additional high growth markets such as extremities. We saw incredible sales growth in 2010 and are executing our 2011 growth plans to expand our product offerings within and outside the United States."
For more information regarding Pioneer's Biologics offerings including Legato, please visit the Pioneer Surgical website at www.pioneersurgical.com.
About Pioneer Surgical Technology, Inc.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopaedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopaedic, Spine, and Biologics divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products, visit www.pioneersurgical.com.
SOURCE Pioneer Surgical Technology, Inc.
